Validation of 3 equations of coronary risk in diabetic population of a primary care center;Validación de tres ecuaciones de riesgo coronario en población diabética de un centro de salud

Medicina Clinica

Volumn 126, Issue 13, 2006, Pages 485-490

  Cañón Barroso, Lourdes ^a   Cruces Muro, Eloísa ^a   Fernández Ochoa, Gerardo ^a   Nieto Hernández, Teresa ^a   García Vellido, Andrés ^a   Buitrago, Francisco ^a,b  

^a Centro de Salud Universitario La Paz   (Spain)

^b NONE   (Spain)

Author keywords

Coronary risk; Diabetes; Equations of cardiovascular risk

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; SCORING SYSTEM; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

EID: 33646521513     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13086846     Document Type: Article

References (29)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Educacion Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285:2486-97.
2. Wood D, De Backer G, Faegerman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recomendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J. 1998;19:1434-503.
3. Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;109: 3112-21.
4. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany: results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003;24:937-45.
5. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart risk function from an italian population study. Eur Heart J. 2000;21:365-70.
6. Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovás J, et al. An adaptation of the Framingham coronary risk function to southern Europe Mediterranean areas. J Epidemiol Community Health. 2003;57:634-8.
7. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovás J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003; 56:253-61.
8. Ramos R, Solanas P, Cordón F, Rohlfs I, Elosua R, Sala J, et al. Comparación de la función de Framingham original y la calibrada del REGICOR en la predicción del riesgo coronario poblacional. Med Clin (Barc). 2003;121:521-6.
9. De Backer G, Ambrosioni E, Broch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. Executive summary. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601-10.
10. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24: 987-1003.
11. Maigues A, Antón F, Franch M, Albert X, Aleixandre E, Collado A. Riesgo cardiovascular del SCORE comparado con el de Framingham. Consecuencias del cambio propuesto por las Sociedades Europeas. Med Clin (Barc). 2004;123:681-5.
12. Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002;156:714-9.
13. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991; 83:356-62.
14. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Predicition of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-47.
15. Aranceta J, Pérez C, Foz M, Mantilla T, Serra L, Moreno B, et al, y grupo DORICA. Tablas de evaluación del riesgo coronario adaptadas a la población española. Estudio DORICA. Med Clin (Barc). 2004;123:686-91.
16. National Diabetes Data Group. Clasification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28: 1039-57.
17. World Health Organization. Expert Committee on Diabetes Mellitus. Third Report of Diabetes Mellitus. Geneva: WHO; 1985. WHO Technical Report Series 727.
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on The Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20:1183-97.
19. D'Agostino RB, Grundy S, Sullivan LM, Wilson P, for the CHD Risk Prediction Group. Validation of the Framingham Coronary Heart Disease Prediction Scores. Results of a multiple ethnic groups investigation. JAMA. 2001;286:180-7.
20. Ramos R, Marrugat J. Valoración del riesgo cardiovascular en la población. En: Alfonso del Río Ligorit, editor. Manual de cardiología preventiva. Madrid: SMC; 2005. p. 43-55.
21. Kanaya AM, Grady D, Barreto-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med. 2002; 162:1735-45.
22. Jimeno J, Molist N, Franch J, Serrano V, Serrano L, Gracia R. Variabilidad en la estimación del riesgo coronario en la diabetes mellitus tipo 2. Aten Primaria. 2005;35:30-6.
23. Hernáez R, Choque L, Giménez M, Costa A, Márquez JI, Conget I. Estimación del riesgo coronario en pacientes con diabetes mellitus tipo 2. ¿Escalas de población general o escalas específicas? Rev Esp Cardiol. 2004;57:577-80.
24. Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR, on behalf of the United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci. 2001;101:671-9. Disponible en: http://www.dtu.ox.ac.uk
25. De la Peña A, Suárez C, Cuende I, Muñoz M, Garré J, Camafort M, et al. Control integral de los factores de riesgo en pacientes de alto y muy alto riesgo cardiovascular en España. Estudio CIFARC. Med Clin (Barc). 2005;124:44-9.
26. Álvarez-Sala LA, Suárez C, Mantilla T, Franch J, Ruilope LM, Banegas JR, et al, en nombre del grupo PREVENCAT. Estudio PREVENCAT: control del riesgo cardiovascular en atención primaria. Med Clin (Barc). 2005;124:406-10.
27. Masana L, Cálculo del riesgo cardiovascular global. ¿Una utopía? Med Clin (Barc). 2004;123:702-3.
28. Brotons C. Control de los factores de riesgo cardiovascular en atención primaria. ¿Controlamos las factores o controlamos el riesgo? Med Clin (Barc). 2005;124:415-6.
29. Villar F. La prevención cardiovascular en España. Promoviendo el uso de las recomendaciones. Rev Esp Salud Pública. 2004;78:421-34.